Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., July 27 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the Wedbush Securities Life Science Best Ideas MAC Conference 2010 on Tuesday, August 3, 2010 at 4:10 p.m. ET at the LeParker Meridien hotel, New York City and at the BMO Capital Markets 10th Annual Focus on Healthcare Conference on August 5, 2010 at 4:00 p.m. ET at the Sheraton New York Hotel & Towers, New York City.

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com.  Please log in approximately 5-10 minutes before the event to ensure a timely connection.  The archived replay will be available on the Idenix website for two weeks following the conference.  

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceuticals Contact:

Jonae Barnes [phone] (investors)

SOURCE Idenix Pharmaceuticals, Inc.

Copyright y 27 PR Newswire